Besides CRF1 receptor antagonists, activation of CRF2 with two selective agonists, urocortin 2 (UCN 2) and urocortin 3 (UCN 3), reversed depression- and anxiety-like behaviors (Bagosi et al., 2016). The gene discussed is CRHR2; the disease is depressive disorder.